Testing Delivery Modalities of Team-Based CBT for Pediatric Anxiety in Community Health Settings.
Recruiting · NCT06934525 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The purpose of this study is to test how the delivery of Cognitive Behavioral Therapy (CBT) for pediatric anxiety and OCD via different methods might increase its availability and effectiveness. CBT involves teaching the patient skills to enable them to gradually come into contact with feared situations. This process of gradually approaching feared situations is called exposure. Although CBT with exposure has the best evidence for treating anxiety disorders, not all children have equal access or respond the same way to CBT. As part of this study, patients will receive weekly CBT treatment sessions involving a combination of weekly visits with an exposure coach and one visit a month with a licensed provider (e.g., social worker) who also provides weekly supervision for the exposure coach. This treatment will be delivered using one of three methods: 1) in-person (face-to-face sessions, occurring in the office and the home/community), or 2) telehealth (entirely remote sessions via web-based video conference), or 3) flexible (individualized mix of in-person and/or telehealth sessions). Eligible participants will be randomly assigned to one of these three methods. Results of this study will help determine which treatment method works best for whom. Treatment as described above will occur as part of care at partnering community care sites in Rhode Island. Providers from the following partnering community care sites will make up patient treatment teams: Blackstone Valley Community Health Care, Family Services of Rhode Island, Gateway Healthcare, Newport Mental Health, and Thrive Behavioral Health. The research study is being conducted by the Pediatric Anxiety Research Center at Brown University Health. The research team will conduct the study assessments that patients will be asked to participate in as study participants. Patients will be asked to complete assessments prior to starting treatment, at two time points during treatment, at the end of treatment, and at two timepoints 3 and 6 months following the end of treatment. Participants will be compensated for their time completing research assessments.
Who can take part
Inclusion criteria
- Age 5-18 inclusive
- Primary or co-primary DSM-V diagnosis of anxiety or OCD
- Symptom duration of at least 3 months
- Outpatient care needed
- Presence of a stable parent, or guardian, who can participate in treatment
Exclusion criteria
- Other primary or co-primary psychiatric disorder which requires initiation of other active current treatment
- Acute suicidality
- Concurrent psychotherapy
- Chronic medical illness that would preclude their active participation in treatment
- Treatment with psychotropic medication that is not stable
Where it is running
1 location listed across 1 US state.
- Bradley Hospital - East Providence, Rhode Island, United States